Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis

RecruitingOBSERVATIONAL
Enrollment

1,300

Participants

Timeline

Start Date

January 27, 2021

Primary Completion Date

August 31, 2024

Study Completion Date

January 31, 2028

Conditions
Cerebral Venous Thrombosis
Interventions
DRUG

Oral anticoagulant

Direct oral anticoagulants or vitamin K antagonists. Please note that the study is fully observational. The choice of anticoagulant type and duration of treatment are left at the discretion of the treating physicians and patients. No treatment, intervention, or examinations are imposed on patients in the context of this study.

Trial Locations (1)

1105AZ

RECRUITING

Jonathan Coutinho, Amsterdam

All Listed Sponsors
collaborator

University of Lisbon

OTHER

collaborator

Sahlgrenska University Hospital

OTHER

collaborator

University of Helsinki

OTHER

collaborator

Centro Hospitalar de Lisboa Central

OTHER

lead

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

OTHER